Marina R. Kasimova

Marina R. Kasimova is a Principal Scientist in Analytical Development at Y-mAbs Therapeutics, Inc., and an external examiner at the University of Copenhagen. With extensive experience as a Senior Formulation Scientist at Nykode Therapeutics and as a Senior CMC Specialist at Genmab, Marina has expertise in formulation development for pDNA drug candidates and pharmaceutical technology. Prior roles include Senior Scientist at Symphogen, where responsibilities encompassed formulation development for clinical trials and laboratory establishment, as well as consulting as the Founder/Owner of Protein Solutions. Marina's academic background includes a PhD in Molecular Biophysics from The Johns Hopkins University and multiple degrees from the Moscow Institute of Physics and Technology, establishing a strong foundation in biophysics and drug formulation.